US President Joe Biden signed the “National Biotechnology and Biomanufacturing Initiative”, an executive order designed to ensure that bio-technologies invented in the U.S. are manufactured in the U.S., contributing to job creation, stronger supply-chain security and lower prices. This move draws attention as it is expected to affect South Korean bio businesses. Click the news below for more information:

https://world.kbs.co.kr/service/news_view.htm?lang=e&Seq_Code=172339